LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism in the United System. The company offers LENSAR Laser System which incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes by providing imaging, procedure planning, design, and precision. It also provides ALLY Robotic Cataract Laser System, a compact cataract treatment system that is designed to allow surgeons to perform sterile laser-assisted cataract surgery in a single operating room. LENSAR, Inc. was incorporated in 2004 and is headquartered in Orlando, Florida.

LENSAR, Inc.

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Candel Therapeutics (CADL), LENSAR (LNSR) and Pyxi...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	LNSR	$8.09	-1.34%	89.13K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	LNSR	$8.09	-1.3%	89.13K
3
4
5
6

LNSR

Get LENSAR, Inc. Data in Excel

Get LENSAR, Inc. Data in Excel